Cohort of STEMI Patients 2

Last updated: January 3, 2025
Sponsor: Hospices Civils de Lyon
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hypercholesterolemia

Cardiac Disease

Angina

Treatment

MRI

Quality of life questionaries

Biocollection

Clinical Study ID

NCT05794022
69HCL22_0991
  • Ages > 18
  • All Genders

Study Summary

ST-segment elevation myocardial infarction (STEMI) is an acute condition that accounts for 75% of sudden deaths in adults over 35 years of age and more than half of all cases of chronic heart failure. However, the mechanism of myocardial infarction remains poorly understood. At present, there is no national information system for myocardial infarction, as there is for other diseases such as multiple sclerosis (OFSEP cohort).

The purpose of this cohort is to enable studies and research projects to be carried out on the descriptive epidemiology of myocardial infarction, monitoring of patients undergoing treatment (safety, efficacy), quality of life and functional consequences of infarction, and research into new biological and imaging prognostic biomarkers. Its general objective is to provide researchers, hospital practitioners, medical interns, academics or industrialists with a quality epidemiological tool for research.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age ≥ 18 years

  • Diagnosis of STEMI defined by ST segment elevation ≥ 0.2 mV in 2 contiguous leads ona 12-lead ECG.

  • Management in primary ACT

  • Prior oral informed consent followed by signed informed consent as soon as possible.

Exclusion

Exclusion Criteria:

  • Diagnosis of STEMI not confirmed on angiography

  • Inability to give the subject informed information

  • Lack of coverage by a social security scheme

  • Obvious contraindication to injected magnetic resonance imaging (claustrophobia,pacemaker, defibrillator, or a metallic body (ferromagnetic), severe renalinsufficiency (GFR<30 ml/min), known allergy to the contrast medium ....)

  • Pregnant woman or woman of childbearing age without effective contraception,breastfeeding woman.

  • Deprivation of civil rights (curators, guardianship, safeguard of justice)

Study Design

Total Participants: 300
Treatment Group(s): 3
Primary Treatment: MRI
Phase:
Study Start date:
May 03, 2023
Estimated Completion Date:
June 03, 2031

Connect with a study center

  • Hospices Civils de Lyon - Hôpital Louis Pradel

    Bron, Rhone 69500
    France

    Active - Recruiting

  • Hospices Civils de Lyon - Hôpital de la Croix Rousse

    Lyon, Rhone 69004
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.